Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Hang Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6697-409X; OpenAlex author ID A5045331047. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment. Co-author DOI 10.1002/advs.76575↗
  2. Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1186/s12866-024-03371-9↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Wang · 1 shared paper, 2026 · strength 0.25
  2. Tianli Luo · 1 shared paper, 2026 · strength 0.25
  3. Ajay Goel · 1 shared paper, 2026 · strength 0.25
  4. Yuhua Zhang · 1 shared paper, 2024 · strength 0.18
  5. Wenkai Ye · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.